SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 12b-25
Commission File Number: 000-27353
NOTIFICATION OF LATE FILING
(Check One)
[ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-QSB
[ ] Form N-SAR [ ] Form 10KSB
For period Ended: March 31, 2000
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: __________________________
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates._________________________
________________________________________________________________________________
PART I
REGISTRANT INFORMATION
SELECT THERAPEUTICS INC.
Full Name of Registrant
________________________________________________________________________________
Former Name if Applicable
124 Mt. Auburn Street, Suite 200 North
Address of Principal Executive Office (Street and Number)
Cambridge, MA 02138
City, State and Zip Code
<PAGE>
PART II
RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12-b-25(b), the
following should be completed. (Check appropriate box.) [X] Yes [ ] No
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, 20-F, 11-K or N-SAR, or portion thereof, will be filed on
or before the 15th calendar day following the prescribed due date; or
the subject quarterly report or transistion report on Form 10-Q, or
the portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
Due to the company's recent hiring of an outside accountant who prepares
its unaudited financial statements, the Company required additional time to
complete the subject Form 10-Q.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Richard G. Klein, Esq. (212) 818-9000
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 2 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s). [X] Yes [ ] No
-2-
<PAGE>
(3) Is it anticipated that any significant change in results of operation for
the corresponding period for the last fiscal year will be reflected by
earnings statements to be included in the subject report or portion
thereof? [ ] Yes [X] No
If so: attached an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reason why a reasonable
estimate of the results cannot be made.
SELECT THERAPEUTICS INC.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: May 16, 2000 By: /s/ Robert Bender
----------------------------
Chairman
-3-
